From May 27 to 29， 2021, the Company accepted and passed the Vaccination inspections on Group A and Group C Meningococcal Conjugate Vaccine,、Haemophilus Influenzae Type b Conjugate Vaccine by the National Center for vaccine inspection.
The inspection is detailed in the following table. Besides, no penalties were made against the Company’s products due to quality since their launch.
Inspection Statistics | ||||
S/N | Time | Institute | Details | Results |
1 | May 27 to 29, 2021 | National Center for vaccine inspection | Group A and Group C Meningococcal Conjugate Vaccine,、Haemophilus Influenzae Type b Conjugate Vaccine | Passed |
On October 20, 2020, the Company accepted and passed the GMP compliance inspection and defect rectification review on Group A and Group C Meningococcal Conjugate Vaccine by the inspection team organized by Sichuan Medical Products Administration.
On October 22, 2020, the Company accepted and passed the on-site inspections on the Company’s renewal of Drug Manufacturing Certificate upon expiration of its validity by the inspection team organized by Sichuan Medical Products Administration.
The inspection is detailed in the following table. Besides, no penalties were made against the Company’s products due to quality since their launch.
Inspection Statistics
S/N | Time | Institute | Details | Results |
1 | October 20, 2020 | Sichuan Medical Products Administration | GMP compliance inspection and defect rectification review on Group A and Group C Meningococcal Conjugate Vaccine | Passed |
2 | October 22, 2020 | Sichuan Medical Products Administration | On-site inspections on the renewal of Drug Manufacturing Certificate upon expiration of its validity | Passed |
On August 18, 2020, the Company accepted and passed the on-site inspection on the changes of the newly added Finished Products Warehouse 8 by the vaccine field inspector appointed by Sichuan Medical Products Administration.
The inspection is detailed in the following table. Besides, no penalties were made against the Company’s products due to quality since their launch.
Inspection Statistics
S/N | Time | Institute | Details | Results |
1 | August 18, 2020 | Sichuan Medical Products Administration | On-site inspection on the changes of the newly added Finished Products Warehouse 8 | Passed |
On September 9, 2020, the Company accepted and passed the review on the production site rectification of the Company by the inspection team organized by Sichuan Center for Food and Drug Evaluation, Inspection & Monitoring.
From September 28 to 29, 2020, the Company accepted and passed the inspection on the Company’s adverse drug reaction report and testing by the inspection team organized by Sichuan Center for Food and Drug Evaluation, Inspection & Monitoring.
The inspection is detailed in the following table. Besides, no penalties were made against the Company’s products due to quality since their launch.
Inspection Statistics
S/N | Time | Institute | Details | Results |
1 | September 9, 2020 | Sichuan Center for Food and Drug Evaluation, Inspection & Monitoring | Review of production site rectification after national inspection and defect rectification | Passed |
2 | September 28 to 29, 2020 | Sichuan Center for Food and Drug Evaluation, Inspection & Monitoring | Inspection on the Company’s adverse drug reaction report and testing | Passed |